Unknown

Dataset Information

0

Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women.


ABSTRACT: Background:Attenuated varicella zoster virus (VZV) is a promising vector for recombinant vaccines. Because human immunodeficiencyvirus (HIV) vaccines are believed to require mucosal immunogenicity, we characterized mucosal VZV-specific humoral immunity following VZVOka vaccination. Methods:Adult Kenyan VZV-seropositive women (n = 44) received a single dose of the live zoster VZVOka vaccine. The anamnestic responses to the virus were followed longitudinally in both plasma and mucosal secretions using an in-house glycoprotein enzyme-linked immunosorbent assay and safety and reactogenicity monitored. VZV seroprevalence and baseline responses to the virus were also characterized in our cohorts (n = 288). Results:Besides boosting anti-VZV antibody responses systemically, vaccination also boosted anti-VZV immunity in the cervicovaginal mucosa with a 2.9-fold rise in immunoglobulin G (P < .0001) and 1.6-fold rise in immunoglobulin A (IgA) (P = .004) from the time before immunization and 4 weeks postvaccination. Baseline analysis demonstrated high avidity antibodies at the gastrointestinal and genital mucosa of VZV-seropositive women. Measurement of VZV-specific IgA in saliva is a sensitive tool for detecting prior VZV infection. Conclusions:VZVOka vaccine was safe and immunogenic in VZV-seropositive adult Kenyan women. We provided compelling evidence of VZV ability to induce genital mucosa immunity. Clinical Trials Registration:NCT02514018.

SUBMITTER: Perciani CT 

PROVIDER: S-EPMC6129112 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women.

Perciani Catia T CT   Sekhon Manmeet M   Hundal Sabrina S   Farah Bashir B   Ostrowski Mario A MA   Anzala A Omu AO   McKinnon Lyle R LR   Jaoko Walter W   MacDonald Kelly S KS  

The Journal of infectious diseases 20180901 8


<h4>Background</h4>Attenuated varicella zoster virus (VZV) is a promising vector for recombinant vaccines. Because human immunodeficiencyvirus (HIV) vaccines are believed to require mucosal immunogenicity, we characterized mucosal VZV-specific humoral immunity following VZVOka vaccination.<h4>Methods</h4>Adult Kenyan VZV-seropositive women (n = 44) received a single dose of the live zoster VZVOka vaccine. The anamnestic responses to the virus were followed longitudinally in both plasma and mucos  ...[more]

Similar Datasets

| S-EPMC5623463 | biostudies-literature
2018-10-18 | GSE121385 | GEO
| S-EPMC2839977 | biostudies-literature
| S-EPMC4789179 | biostudies-literature
| S-EPMC87343 | biostudies-literature
| S-EPMC4965400 | biostudies-literature
| S-EPMC7115581 | biostudies-literature
| S-EPMC2915977 | biostudies-literature
| S-EPMC8778750 | biostudies-literature
| S-EPMC6819919 | biostudies-literature